Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07105592
What this trial is testing

Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 68
Large-scale testing (Phase 3)UnknownNCT01039298
What this trial is testing

Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL

Who this might be right for
Oral CancerHigh-grade Precancer
University of British Columbia 200
Testing effectiveness (Phase 2)WithdrawnNCT04001413
What this trial is testing

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03330249
What this trial is testing

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 124
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735
What this trial is testing

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Who this might be right for
Microsatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more
M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Looking for participantsNCT05985655
What this trial is testing

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Early research (Phase 1)Ended earlyNCT00906360
What this trial is testing

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+29 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT06727617
What this trial is testing

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Who this might be right for
Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital 134
Not applicableLooking for participantsNCT06385717
What this trial is testing

Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer

Who this might be right for
Esophagus Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT04671667
What this trial is testing

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT01511328
What this trial is testing

Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm

Who this might be right for
High-grade Cervical Intraepithelial NeoplasiaInvasive Cervical Cancer
Karolinska Institutet 270,000
Not applicableStudy completedNCT02651883
What this trial is testing

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

Who this might be right for
Cervical CancerUterine Cervical NeoplasmsHuman Papillomavirus
UNC Lineberger Comprehensive Cancer Center 665
Testing effectiveness (Phase 2)Looking for participantsNCT06440850
What this trial is testing

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Oncocytic CarcinomaThyroid Gland Papillary Carcinoma
City of Hope Medical Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04223024
What this trial is testing

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 246
Not applicableStudy completedNCT00984074
What this trial is testing

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Abramson Cancer Center at Penn Medicine 3
Large-scale testing (Phase 3)Study completedNCT00193830
What this trial is testing

High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix

Who this might be right for
Cancer of CervixCervical CancerCancer of the Cervix+1 more
Tata Memorial Hospital 750
Not applicableUnknownNCT04127435
What this trial is testing

High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors

Who this might be right for
Cervical Cancer
Peking University Third Hospital 50
Early research (Phase 1)WithdrawnNCT01491139
What this trial is testing

Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
University College, London
Not applicableUnknownNCT04303975
What this trial is testing

The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaHead and Neck CancerToxicity Due to Radiotherapy
Jiarong Chen, MD 300
Next Page
188